ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Cutting Edge: EZH2 Promotes Osteoclastogenesis by Epigenetic Silencing of the Negative Regulator IRF8.

Celestia Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.